Lenalidomide (CC-5013) | Immunomodulator - MedChemExpress

• •Nucleic Acid Gel Electrophoresis
• •Vector Construction
• •Restriction Endonuclease
• •Materials
• •PCR & qPCR
• •RT-PCR
• •Sequencing

• •Protein Sample Preparation
• •Protein Purification
• •Protein Electrophoresis & WB
• •Multiple Fluorescent Staining
• •Immunoassay
• •Immunoprecipitation Kit
• •Labeling Kit

• •Cell Culture
• •Cell Analysis
• •3D Cell Culture
• •Cell Isolation

• Cytokines and Growth Factors
• Immune Checkpoint Proteins
• CAR-T Related Proteins
• CD Antigens
• Fc Receptors
• Receptor Proteins
• Enzymes & Regulators
• Complement System
• Ubiquitin Related Proteins
• Viral Proteins
• Biotinylated Proteins
• Fluorescent-labeled Recombinant Proteins
• GMP-grade Proteins
• Animal-free Recombinant Proteins
• Others
• View More

• Interleukin & Receptors
• Interferon & Receptors
• Chemokine & Receptors
• TNF Superfamily
• CSF & Receptors
• TGF-beta Superfamily
• PDGFs & PDGFRs
• VEGF & VEGFR
• EGF Superfamily
• FGF Family
• HGF & Receptors
• Neurotrophic Factors
• Ephrin/Eph Family
• Angiopoietins
• IGF family
• Peptide Hormone & Neuropeptides

• Inhibitory Checkpoint Molecules
• Stimulatory Immune Checkpoint Molecules
• Butyrophilins

• CD27 Ligand/CD70
• CD4
• CD19
• CD27 Ligand/CD70
• CD123
• CD138/Syndecan-1
• Epithelial Cell Adhesion Molecule (EpCAM)
• Folate Receptor 1
• GPC-3
• Guanylate Cyclase 2C
• ErbB2/HER2
• ErbB3/HER3
• c-Met/HGFR
• MSLN
• CA-125
• ROR1
• CEACAM-5
• CD314/NKG2D
• Prostate Specific Membrane Antigen
• CD319/SLAMF7
• TROP-2
• Siglec-6
• Folate Receptor alpha (FR-alpha)
• CD314/NKG2D
• Siglec-3/CD33
• CD27 Ligand/CD70
• CD319/SLAMF7
• ErbB2/HER2
• Siglec-3/CD33
• CD7
• MUC-1/CD227

• T Cell CD Proteins
• B Cell CD Proteins
• NK Cell CD Proteins
• Macrophage CD Proteins
• Monocyte CD Proteins
• Stem Cell CD Proteins
• Platelet CD Proteins
• Erythrocyte CD Proteins
• Dendritic Cell CD Proteins
• Epithelial cell CD Proteins
• Endothelial cell CD Proteins
• Signal Transduction-related CD Proteins
• Cell Adhesion-related CD Proteins

• Fc-gamma Receptor
• FcRn
• Fc-epsilon Receptor
• Fc alpha/mu Receptor
• Polymeric Immunoglobulin Receptor
• FcμR
• Fc Receptor-like Proteins
• Immunoglobulin Fc Region
• Fc alpha RI/CD89

• Receptor Tyrosine Kinases
• Receptor Serine/Threonine Kinases
• Receptor Tyrosine Phosphatase
• Receptor Guanylyl Cyclase Family
• Cell Adhesion Molecules (CAMs)
• G-Protein-Coupled Receptors (GPCRs)
• Nuclear Receptor Superfamily
• Pattern Recognition Receptors
• Notch family
• Siglec
• Leukocyte Immunoglobin-like Receptors
• Killer-Cell Immunoglobulin-like Receptors
• Cytokine Receptors

• Oxidoreductases (EC 1)
• Transferases (EC 2)
• Hydrolases (EC 3)
• Lyases (EC 4)
• Isomerases (EC 5)
• Ligases (EC 6)
• Translocases (EC 7)
• Matrix Metalloproteinases
• ADAMs/ADAMTSs
• Cathepsin
• Carboxypeptidase
• Angiotensin-converting Enzymes
• Caspase
• Carbonic Anhydrase
• Serine/Threonine Kinase Proteins
• Protein Tyrosine Kinases
• Phosphatase
• Topoisomerase
• Protease Inhibitors
• Protein Kinase Inhibitor Peptide (PKI)
• Cyclin-Dependent Kinase Inhibitor Proteins
• Cystatin Family

• Complement Component 1
• Complement Component 2
• Complement Component 3
• Complement Component 4
• Complement Component 5
• Complement Component 6
• Complement Component 7
• Complement Component 8
• Mannose-binding Protein
• MASP-1
• MASP-2
• Complement Regulatory Proteins
• Complement Receptor
• Complement Component 9

• Ubiquitin/UBLs
• Ubiquitin Enzymes
• Deubiquitinase

• SARS-CoV-2 Proteins
• Zika Virus Proteins
• RSV Proteins
• Hepatitis C Virus Proteins
• Hepatitis B Virus Proteins
• HIV Proteins
• HPV Proteins
• Influenza Viruses Proteins
• Dengue Virus Proteins
• Ebola Virus Proteins
• Bacterial/Fungal Proteins
• CHIKV

• Molecular Biology
• •Nucleic Acid Gel Electrophoresis
• •Vector Construction
• •Restriction Endonuclease
• •Materials
• •PCR & qPCR
• •RT-PCR
• •Sequencing
• Protein Biology
• •Protein Sample Preparation
• •Protein Purification
• •Protein Electrophoresis & WB
• •Multiple Fluorescent Staining
• •Immunoassay
• •Immunoprecipitation Kit
• •Labeling Kit
• Cell Biology
• •Cell Culture
• •Cell Analysis
• •3D Cell Culture
• •Cell Isolation
• View More

• Nucleic Acid Gel Stain
• Agarose
• Loading & Running Buffer
• DNA Marker

• Seamless Cloning
• Ligase
• Endonuclease

• Polymerase Chain Reaction (PCR)
• Real-Time PCR
• DNA Polymerase

• Reverse transcription PCR
• RNase Inhibitor

• Enzymes

• Cell Lysis
• Washing Buffer
• Protease Inhibitor Cocktail
• Phosphatase Inhibitor Cocktail
• Deacetylase Inhibitor Cocktail
• Kinase Inhibitor Cocktail
• Protein Assay

• Magnetic Stand
• Magnetic Beads
• Affinity Chromatography Column
• Agarose Beads
• Equilibration Buffer
• Magnetic Agarose Beads

• Electrophoresis Buffer
• Protein Marker
• Transfer Buffer
• Blocking Buffer
• Binding/Washing Buffer
• Chemiluminescent Detection
• Loading Buffer
• Protein Staining Solution
• Gel Preparation Kit
• Antibody Dilution Buffer
• Protein Gel

• Cell Transfection
• Mycoplasma Clearance
• Sterile Antibiotic Solution
• Cell Freezing
• CEPT cocktail
• Basal Cell Culture Media
• Balanced Salt Solutions
• Cell Culture Supplements
• Dissociation Reagents
• Cell Separation Media
• Specialized Cell Culture Medium
• Lentivirus

• Cell Proliferation and Cytotoxicity
• Reporter Gene Testing
• Phalloidin Dye Conjugates
• Cell Apoptosis and Necrosis
• AntiFade Mounting Medium
• Mitochondrial Isolation
• Exosome Isolation, Purification and Detection
• Organelle Research
• Metabolism Assay Kit
• Mycoplasma Detection
• Biochemical Assay Kit
• Endotoxin Detection

• Basement Membrane Matrix
• Tumor Organoid Culture Medium
• Normal Tissue Organoid Culture Medium
• Organoid Research

• Topics
• Articles
• Product Guides
• Learning & Download
• Biomedical Dictionary
• Blogs
• Protocols

• Exhibition Events
• Promotion
• MCE Webinar

• Quality Management System
• Custom Synthesis Service
• Bulk and Custom Synthesis Service
• ADC-Related Custom Services
• PROTAC-Related Custom Services
• Custom Reference Standard Products
• Custom Peptide Synthesis
• Protein Expression Service
• Recombinant Antibody Expression Service
• Protein Crystal Structure Elucidation
• Oligonucleotide Synthesis
• Gene Regulation Tool
• • Lentivirus Packaging
• • Adenovirus Packaging
• • Adeno Associated Virus Packaging
• Fluorescent Labeling Service
• Custom Synthesis of Stable Isotope-Labeled Compounds
• One-stop CDMO Service
• One-stop Compound Screening Platform
• Virtual Screening
• Molecular Dynamics Simulation
• Cell-based Compound Screening
• Ion Channel Screening
• Kinase Screening Service
• SPR Assay Service
• GPCR Bioassay Screening Services
• Nuclear Receptor Screening Services
• Affinity Mass Spectrometry
• DEL Synthesis and Screening
• Molecular Interaction Assay Service
• Drug Target Identification Service
• AI Driven Drug Screening
• Molarity Calculator
• Dilution Calculator

• Careers

1. PROTAC Apoptosis
2. Ligands for E3 Ligase Molecular Glues Apoptosis
3. Lenalidomide

Solubility

In Vivo Dissolution Calculator

Help & FAQs

Lenalidomide (CC-5013), a derivative of Thalidomide, acts as molecular glue. Lenalidomide is an orally active immunomodulator. Lenalidomide (CC-5013) is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. Lenalidomide (CC-5013) specifically inhibits growth of mature B-cell lymphomas, including multiple myeloma, and induces IL-2 release from T cells.

For research use only. We do not sell to patients.

Lenalidomide Chemical Structure

CAS No. : 191732-72-6

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 60 publication(s) in Google Scholar

Other Forms of Lenalidomide:

• Lenalidomide-d5 In-stock
• Lenalidomide hemihydrate In-stock
• Lenalidomide (Standard) In-stock
• Lenalidomide-13C5,15N Get quote
• Lenalidomide-d4 Get quote
• rac-Lenalidomide-13C5 Get quote
• Lenalidomide hydrochloride Get quote

Lenalidomide Related Antibodies

56 Publications Citing Use of MCE Lenalidomide

• •Nature. 2024 Sep;633(8030):670-677. [Abstract]
• •Cancer Cell. 2022 Nov 14;40(11):1294-1305.e4. [Abstract]
• •Nat Cancer. 2022 May;3(5):595-613. [Abstract]
• •Cell. 2018 Sep 20;175(1):171-185.e25. [Abstract]
• •Nat Commun. 2025 Nov 6;16(1):9805. [Abstract]
• •Nat Commun. 2025 Sep 1;16(1):8155. [Abstract]

• •Cancer Res. 2025 Jan 2;85(1):101-117. [Abstract]
• •Nat Commun. 2017 May 22;8:15398. [Abstract]
• •Cell Rep Med. 2025 Apr 2:102053. [Abstract]
• •Microbiome. 2025 Feb 28;13(1):56. [Abstract]
• •Leukemia. 2025 Mar;39(3):720-733. [Abstract]
• •Cell Rep Med. 2024 Mar 19;5(3):101472. [Abstract]
• •Nat Chem Biol. 2021 Jun;17(6):711-717. [Abstract]
• •Cell Commun Signal. 2025 May 7;23(1):216. [Abstract]
• •Acta Pharmacol Sin. 2025 Mar 25. [Abstract]
• •Free Radic Biol Med. 2023 Jul:203:86-101. [Abstract]
• •Acta Pharmacol Sin. 2020 Sep;41(9):1246-1254. [Abstract]
• •Neoplasia. 2025 Oct 27:70:101243. [Abstract]
• •J Transl Med. 2024 Dec 3;22(1):1095. [Abstract]
• •Cell Rep. 2024 May 8;43(5):114211. [Abstract]
• •Elife. 2018 Aug 1;7:e38430. [Abstract]
• •Cell Syst. 2018 Apr 25;6(4):424-443.e7. [Abstract]
• •Eur J Pharmacol. 2025 Dec 5:1008:178303. [Abstract]
• •Int Immunopharmacol. 2025 May 14:158:114831. [Abstract]
• •Mol Ther Oncol. 2025 Feb 20;33(1):200952. [Abstract]
• •ACS Omega. 2024 Dec 3;9(50):49739-49748. [Abstract]
• •Cell Rep Methods. 2023 Oct 23;3(10):100599. [Abstract]
• •Cancers (Basel). 2024 Mar 28, 16(7), 1319.
• •Int J Mol Sci. 2023 Sep 14;24(18):14097.
• •Cancer Sci. 2019 Dec;110(12):3802-3810. [Abstract]
• •Front Cell Infect Microbiol. 2022 Jul 28;12:954814. [Abstract]
• •iScience. 2022 Jul 19;25(8):104781.
• •Biochim Biophys Acta Mol Basis Dis. 2022 Oct 1;1868(10):166472. [Abstract]
• •Inflammation. 2019 Feb;42(1):221-234. [Abstract]
• •Bioengineering (Basel). 2025 Oct 19;12(10):1121. [Abstract]
• •Clin Chim Acta. 2024 Jan 15:553:117707. [Abstract]
• •ACS Pharmacol Transl Sci. 2021 Feb 26;4(2):941-952.
• •Exp Cell Res. 2020 Aug 1;393(1):112054. [Abstract]
• •Food Chem Toxicol. 2019 Mar:125:392-402. [Abstract]
• •Oncol Rep. 2018 Jun;39(6):2873-2880. [Abstract]
• •Am J Pathol. 2015 Jun;185(6):1783-94. [Abstract]
• •Chemrxiv. 2025 Nov 17.
• •Harvard University. 2025.
• •bioRxiv. 2024 October 19.
• •Patent. US20240261246A1.
• •bioRxiv. 2024 June 12.
• •Universidad de Navarra. 2024 Feb 28.
• •Patent. US20220332776A1.
• •Oxid Med Cell Longev. 2021 Dec 29:2021:8302831.
• •Patent. US20210379039A1.
• •University of Washington. The Columbian College of Arts and Sciences. August 31, 2021.
• •bioRxiv. April.
• •Patent. US20180263995A1.
• •Patent. US20170360780A1.
• •Faculty of Science, Masaryk University. Department of Experimental Biology.2014.
• •Harvard Medical School LINCS LIBRARY

Lenalidomide purchased from MedChemExpress. Usage Cited in: Cell. 2018 Sep 20;175(1):171-185.e25. [Abstract]

Lenalidomide purchased from MedChemExpress. Usage Cited in: Elife. 2018 Aug 1;7:e38430. [Abstract]

Lenalidomide purchased from MedChemExpress. Usage Cited in: Oncol Rep. 2018 Jun;39(6):2873-2880. [Abstract]

Lenalidomide purchased from MedChemExpress. Usage Cited in: Nat Commun. 2017 May 22;8:15398. [Abstract]

Featured Recommendations

•Related Screening Libraries:

• Apoptosis Compound Library
• Immunology/Inflammation Compound Library
• FDA-Approved Drug Library
• Anti-Cancer Compound Library
• Antiviral Compound Library
• CNS-Penetrant Compound Library
• Drug Repurposing Compound Library
• Ubiquitination Compound Library
• Anti-COVID-19 Compound Library
• NMPA-Approved Drug Library
• Orally Active Compound Library
• FDA Approved & Pharmacopeial Drug Library
• Drug-Induced Liver Injury (DILI) Compound Library
• Anti-Pancreatic Cancer Compound Library
• Anti-Blood Cancer Compound Library
• Transcription Factor-Targeted Library
• Rare Diseases Drug Library
• Protein-protein Interaction Inhibitor Library
• Chemotherapy Drug Library
• EMA-Approved Drug Library
• FDA-Approved Anticancer Drug Library
• Human Metabolite Library
• Anti-Prostate Cancer Compound Library
• E3 Ligase Ligand Library
• Non-steroidal Anti-Inflammatory Compound Library
• Molecular Glue Compound Library
• Heterocyclic Compound Library
• Withdrawn Drug Compound Library
• Off-patent Drug Library
• Highly Selective Activators Library
• Cell Death Library
• Anti-Hematopathy Compound Library
• Bioactive Compound Library Max
• MCE Bioactive Compound Library
• Drug Repurposing Compound Library Plus
• FDA-Approved Drug Library Plus
• FDA-Approved Drug Library Mini
• Bioactive Compound Library Plus
• Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
• High-Throughput Bioactive Compound Library
• Anti-Cancer Approved Drug Library
• Mass Spectrometry Human Metabolite Library
• Cardiotoxic Compound Library
• Posttranslational Modification Library
• Nephrotoxicity Compound Library
• 3D Diverse Fragment Library
• MCE Kinase Hinge Binder Fragment Library
• Molecular Glue-like Compound Library

•Related Small Molecules:

•Related Proteins:

View All Ligands for E3 Ligase Isoform Specific Products:

• Biological Activity

• Protocol

• Purity & Documentation

• References

• Customer Review

• [1]. Krönke J, et al. Lenalidomide induces degradation of IKZF1 and IKZF3. Oncoimmunology. 2014 Jul 3;3(7):e941742.

  [2]. Kotla V, et al. Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol. 2009 Aug 12;2:36.

  [3]. Lopez-Girona A, et al. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia. 2012 Nov;26(11):2326-35.

  [4]. Rozewski DM, et al. Pharmacokinetics and tissue disposition of lenalidomide in mice. AAPS J. 2012 Dec;14(4):872-82.

  [5]. Minzel W, et al. Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models. Cell. 2018 Sep 20;175(1):171-185.e25.

  [6]. Nagashima, Takeyuki, et al. PHARMACEUTICAL COMPOSITION COMPRISING BICYCLIC NITROGEN-CONTAINING AROMATIC HETEROCYCLIC AMIDE COMPOUND AS ACTIVE INGREDIENT. Patent. 20170360780A1.

  [7]. Omran A, et al. Effects of MRP8, LPS, and lenalidomide on the expressions of TNF-α , brain-enriched, and inflammation-related microRNAs in the primary astrocyte culture. ScientificWorldJournal. 2013 Sep 21;2013:208309.

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

• Rating
• Lot Number *
• Submit an Image No file chosen (Maximum size is: 1024 Kb)
• PubMed ID
• If you have published this work, please enter the PubMed ID.
• Show My Name
• Your name will appear on the site.
• Email
• Remarks

Lenalidomide Related Classifications

• Disease Areas
• Cancer Infection Inflammation or Immune System Disease Blood or Cardiovascular Disease Digestive System Disease Urogenital Disease Neurological, Eye or Ear Disease
• Coronavirus Infection Blood Disease Prostate Cancer Urogenital Cancer Leukemia/Lymphoma/Myeloma Pancreatic Cancer Digestive System Cancer Viral Infection Digestive System Inflammation
• SARS-CoV-2 Infection Leukemia/Lymphoma/Myeloma

• Inflammation/Immunology Cancer
• Cancer Targeted Therapy Cancer Immunotherapy Cancer Metabolism and Metastasis

• PROTAC Apoptosis
• Ligands for E3 Ligase Molecular Glues Apoptosis

• Do most proteins show cross-species activity?

  Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Lenalidomide191732-72-6CC-5013CC5013CC 5013Ligands for E3 LigaseMolecular GluesApoptosisE3 ligase-recruiting MoietydegradationIKZF1IKZF3multiplemyelomaanalogimmunomodulatoryE3ligasecereblonCRL4ligandInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name	Requested Quantity *	mg g kg t ml l
Applicant Name *	Salutation	Dr. Prof. Mr. Ms. Mrs. Miss.
Email Address *	Phone Number *
Department	Organization Name *
City	State
Country or Region *	United StatesCanadaUnited KingdomAustraliaChinaGermanyFranceJapanKorea SouthSwitzerland------------------------------AlbaniaAlgeriaArgentinaArmeniaAustraliaAustriaAzerbaijanBahrainBangladeshBarbadosBelarusBelgiumBoliviaBosnia HerzegovinaBrazilBulgariaCameroonCanadaChileChinaColombiaCroatiaCyprusCzech RepublicDenmarkEcuadorEgyptEstoniaFijiFinlandFranceGeorgiaGermanyGibraltarGreeceHong Kong, ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJapanJordanKazakhstanKenyaKorea SouthKuwaitLatviaLebanonLibyaLithuaniaLuxembourgMacedoniaMalaysiaMaltaMexicoMoldovaMonacoMongoliaMontenegroMoroccoNepalNetherlandsNew ZealandNigeriaNorwayOmanPakistanParaguayPeruPhilippinesPolandPortugalPuerto RicoQatarRepublic of BeninRomaniaRussiaSaudi ArabiaSerbiaSingaporeSlovakiaSloveniaSouth AfricaSpainSri LankaSurinameSwedenSwitzerlandSyriaTaiwan, ChinaThailandTunisiaTurkeyUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVenezuelaVietnamZambiaZimbabweMacao, ChinaVaticanAndorraGhanaOther Countries
Please select a local distributor ナミキ商事株式会社 コスモ・バイオ株式会社 重松貿易株式会社
Remarks

Bulk Inquiry

Inquiry Information

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

• [email protected]
• 609-228-6898
• Find Your Local Distributor

Thanks, your subscription has been confirmed. You will hear from us soon.

Submission failed, please try again later.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.